Shah emphasizes that obesity is a chronic disease and, just like any other chronic disease, needs multiple treatment options. He compares its treatment to coronary artery disease, which doctors manage with lifestyle changes, medications, stents or surgery
For patients who want triple-agonist therapy now, there is no FDA-approved option
Expression profiling and genetic alterations of the selenoproteins GI-GPx and SePP in colorectal carcinogenesis
A peptide may affect a pathway related to: Mitochondrial activity Cellular signaling Sleep Inflammation Metabolism Tissue repair That does not prove it extends human lifespan or prevents age-related disease
For some people, the Wegovy pill can be a helpful tool as part of a personalized, long-term plan
The current CBT was in total 9 weeks, thus, this time frame is too narrow to determine treatment-related telomere length alterations